Patent · US Active

2,3-dihydro-1H-indole compounds

US9872853B2 · kind B2 · utility

2Cited by

0References

8Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Jolie Anne Bastian · Indianapolis, US
Jiehao Chen · Westfield, US
Jeffrey Daniel Cohen · Indianapolis, US
James Robert Henry · Indianapolis, US
William Thomas McMillen · Indianapolis, US
Bradley Earl Reaman · Indianapolis, US
Almudena Rubio · Carmel, US
Daniel Jon Sall · Greenwood, US
Gaiying Zhao · Carmel, US

Key dates

Filing date	May 31, 2017
Grant date	Jan 23, 2018
Priority date	—
Expiry date	May 31, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D309/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, more particularly for the treatment of cancer selected from the group consisting of melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, fallopian tube carcinoma, primary peritoneal carcinoma, cervical cancer, gastric cancer, liver cancer, pancreatic cancer, thyroid cancer, glioma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.